HIV clinical trials in New Jersey
6 studies for HIV are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Newark
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- ID Care ( Site 1507), Hillsborough
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831Positive Peers Intervention Clinical Trial
- Infectious Disease Practice- Rutgers University, Newark
Recruiting
Ages 13 to 34 · All sexes · Updated Aug 18, 2026 · NCT06388109A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Hackensack
- GSK Investigational Site, Newark
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07202546Menopausal HT for Women Living With HIV (HoT)
- New Jersey Medical School Clinical Research Center CRS (31786), Newark
RecruitingPhase 4
Ages 40 to 60 · Women · Updated May 22, 2026 · NCT06856174HIV Suicide Prevention With AI-DBT
- New Jersey Community Research Initiative, Newark
- RWJB Infectious Disease, Newark
Recruiting
Ages 50 and older · All sexes · Updated Jan 15, 2026 · NCT07339189From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.